Exact Sciences Corporatio... (EXAS)
NASDAQ: EXAS
· Real-Time Price · USD
46.08
1.09 (2.42%)
At close: Aug 15, 2025, 2:55 PM
Exact Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.94B | 2.83B | 2.76B | 2.69B | 2.61B | 2.53B | 2.5B | 2.41B | 2.3B | 2.2B | 2.08B | 2.01B | 1.94B | 1.85B | 1.77B | 1.76B | 1.71B | 1.55B |
Cost of Revenue | 935.17M | 899.7M | 863.56M | 751.18M | 723.6M | 667.43M | 654.2M | 629.53M | 608.91M | 596.52M | 574.35M | 546.26M | 514.06M | 483.46M | 458.76M | 439.46M | 418.87M | 382.76M |
Gross Profit | 2B | 1.93B | 1.9B | 1.94B | 1.89B | 1.87B | 1.85B | 1.78B | 1.69B | 1.6B | 1.51B | 1.46B | 1.42B | 1.37B | 1.31B | 1.32B | 1.29B | 1.16B |
Operating Income | -1.01B | -1.03B | -1.04B | -235.84M | -189.59M | -244.61M | -214.94M | -262.55M | -401.51M | -477.58M | -577.57M | -683.57M | -713.48M | -732.15M | -855.68M | -1.05B | -1.09B | -986.19M |
Interest Income | 10.94M | 10.94M | 10.94M | 11.58M | 6.25B | 6.25B | 6.27B | 6.27B | 25.08M | 25.08M | 11.11M | 5.7M | 463K | 463K | n/a | n/a | n/a | n/a |
Pretax Income | -1.02B | -1.03B | -1.04B | -210.57M | -172.1M | -237.67M | -201.75M | -281.3M | -434.22M | -522.11M | -632.57M | -727.5M | -746.42M | -751.49M | -842.51M | -1.06B | -1.11B | -1.02B |
Net Income | -1.01B | -1.02B | -1.03B | -214.04M | -175.01M | -240.23M | -204.15M | -282.13M | -431.68M | -516.72M | -623.51M | -716.37M | -734.55M | -745.4M | -595.63M | -811.82M | -864.77M | -774M |
Selling & General & Admin | 1.8B | 1.73B | 1.68B | 1.65B | 1.62B | 1.65B | 1.62B | 1.61B | 1.6B | 1.59B | 1.58B | 1.64B | 1.65B | 1.61B | 1.66B | 1.51B | 1.38B | 1.24B |
Research & Development | 413.93M | 425.91M | 431.21M | 446.51M | 457.86M | 441.07M | 425.88M | 405.23M | 384.6M | 386.59M | 393.42M | 387.63M | 372.18M | 372.33M | 385.65M | 743.56M | 699.67M | 626.11M |
Other Expenses | 804.49M | 804.49M | 832.25M | 91.03M | 74.06M | 97.54M | 92.71M | 92.31M | 106.09M | 108.97M | 110.69M | 111.83M | 99M | 96.47M | 95M | 94.15M | 93.64M | 69.58M |
Operating Expenses | 3.02B | 2.96B | 2.94B | 2.17B | 2.07B | 2.11B | 2.06B | 2.04B | 2.09B | 2.08B | 2.09B | 2.14B | 2.12B | 2.08B | 2.14B | 2.35B | 2.17B | 1.94B |
Interest Expense | 17.86M | 27.8M | 25.93M | 23.53M | 22.46M | 30.17M | 25.61M | 24.48M | 20.4M | 17.1M | 16.78M | 16.03M | 15.47M | 14.18M | 15.73M | 35.41M | 34.13M | 32.3M |
Selling & Marketing Expenses | 797.28M | 601.96M | 388.05M | 354.44M | 332.95M | 457.64M | 594.2M | 746.82M | 639.66M | 535.98M | 581.19M | 655.28M | 785.9M | 907.93M | 861.89M | 744.41M | 684.28M | 608.31M |
Cost & Expenses | 3.95B | 3.86B | 3.8B | 2.92B | 2.8B | 2.77B | 2.71B | 2.67B | 2.7B | 2.68B | 2.66B | 2.69B | 2.63B | 2.56B | 2.6B | 2.79B | 2.59B | 2.32B |
Income Tax Expense | -11.93M | -9.33M | -7.3M | 3.47M | 2.91M | 2.55M | 2.4M | 831K | -2.53M | -5.39M | -9.06M | -11.13M | -11.87M | -6.09M | -246.88M | -244.1M | -244.75M | -249.65M |
Shares Outstanding (Basic) | 188.9M | 186.81M | 185.31M | 184.79M | 184.31M | 182.35M | 181.11M | 180.65M | 180.2M | 178.57M | 177.58M | 177M | 176.36M | 173.98M | 172.45M | 171.98M | 171.49M | 169.43M |
Shares Outstanding (Diluted) | 188.9M | 186.81M | 185.31M | 184.79M | 184.31M | 182.35M | 181.11M | 184.07M | 180.2M | 178.57M | 177.58M | 177M | 176.36M | 174.42M | 172.45M | 171.98M | 171.49M | 169.43M |
EPS (Basic) | -5.43 | -5.51 | -5.57 | -1.17 | -0.95 | -1.32 | -1.14 | -1.59 | -2.43 | -2.92 | -3.54 | -4.1 | -4.23 | -4.32 | -3.46 | -4.97 | -5.46 | -5.01 |
EPS (Diluted) | -5.43 | -5.51 | -5.57 | -1.17 | -0.95 | -1.32 | -1.14 | -1.59 | -2.43 | -2.92 | -3.54 | -4.1 | -4.23 | -4.32 | -3.46 | -4.97 | -5.46 | -5.01 |
EBITDA | -885.75M | -848.74M | -799.27M | 26.28M | 68.3M | 7.44M | 26.62M | -55.89M | -215.1M | -290.63M | -395.98M | -492.73M | -515.19M | -530.48M | -617.69M | -819.53M | -859.66M | -769.21M |
EBIT | -1.01B | -1.03B | -1.02B | -190.28M | -152.21M | -210.51M | -187.13M | -270.57M | -427.57M | -514.45M | -615.82M | -711.5M | -730.98M | -737.34M | -828.22M | -1.02B | -1.06B | -952.19M |
Depreciation & Amortization | 123.33M | 176.32M | 214.86M | 215.88M | 220.51M | 224.92M | 227.53M | 227.02M | 223.37M | 227.73M | 226.19M | 225.13M | 222.14M | 211.78M | 206.21M | 176.81M | 167.2M | 139.21M |